Transactions
Innoviva, Inc.’s strategic repurchase of GlaxoSmithKline plc’s 32% equity stake
Date Announced:
05/20/2021
client:
Innoviva, Inc.
Status:
Closed – 05/25/2021
Value:
$392 million
Date Announced:
05/20/2021
client:
Innoviva, Inc.
Status:
Closed – 05/25/2021
Value:
$392 million
